Effect of endothelin-1 receptor antagonists on histological and ultrastructural changes in the pancreas and trypsinogen activation in the early course of caerulein-induced acute pancreatitis in rats

World Journal of Gastroenterology

Volumn 11, Issue 8, 2005, Pages 1115-1121

  Andrzejewska, Anna ^a   Dlugosz, Jan W ^a   Augustynowicz, Albert ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Acute pancreatitis; Caerulein; Endothelin 1 receptors antagonists; Trypsin; Ultrastructure

Indexed keywords

3 [2 (3,4 DIMETHOXYPHENYL)ETHOXY] 2 (4,6 DIMETHOXY 2 PYRIMIDINYLOXY) 3,3 DIPHENYLPROPIONIC ACID; CERULETIDE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; ENTEROPEPTIDASE; ENZYME PRECURSOR; LU 302146; TRYPSIN; TRYPSINOGEN; UNCLASSIFIED DRUG;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DOSE RESPONSE; DRUG SELECTIVITY; EDEMA; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HISTOPATHOLOGY; MALE; MEDICAL ASSESSMENT; NONHUMAN; PANCREAS NECROSIS; PHAGOSOME; RAT; RATING SCALE; SCORING SYSTEM; TISSUE HOMOGENATE; TREATMENT OUTCOME; ULTRASTRUCTURE;

EID: 14844363857     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i8.1115     Document Type: Article

References (33)

1. Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ, Foitzik T. Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut 2000; 46: 390-394
2. Eibl G, Buhr HJ, Foitzik T. Therapy of microcirculatory disorders in severe acute pancreatitis: What mediators should we block? Intensive Care Med 2002; 28: 139-146
3. Foitzik T, Eibl G, Buhr HJ. Therapy for microcirculatory disorders in severe acute pancreatitis: Comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist. J Gastrointest Surg 2000; 4: 240-246
4. Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ. Endothelin mediates local and systemic disease sequelae in severe experimental pancreatitis. Pancreas 2001; 22: 248-254
5. Foitzik T, Hotz HG, Eibl G, Hotz B, Kirchengast M, Buhr HJ. Therapy of microcirculatory disorders in severe acute pancreatitis: Effectiveness of platelet activating factor receptor blockade vs endothelin receptor blockade. J Gastrointest Surg 1999; 3: 244-251
6. Liu X, Nakano I, Ito T, Kimura T, Nawata H. Is endothelin-1 an aggravating factor in the development of acute pancreatitis? Chin Med J 1999; 112: 603-607
7. B receptor function in pancreatitis-associated microcirculatory failure, inflammation, and parenchymal injury. Am J Physiol 2003; 285: G145-G153
8. Andrzejewska A, Dlugosz JW. The endothelin-1 receptor antagonists ameliorate histology and ultrastructural alterations in the pancreas and decrease trypsinogen activation in severe taurocholate pancreatitis in rats. Int J Exp Path 2003; 84: 221-229
9. B endothelin antagonist ameliorates systemic inflammation in a murine model of acute haemorrhagic pancreatitis. Surgery 1997; 122: 443-449
10. Foitzik T, Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates. Surgery 2000; 127: 399-407
11. Martignoni ME, Ceyhan GO, Ayuni E, Kondo Y, Zimmermann A, Büchler MW, Friess H. Endothelin receptor antagonists are not beneficial in the therapy of acute experimental pancreatitis. Langenbeck's Arch Surg 2004; 389: 184-192
12. Fiedler F, Ayasse D, Rohmeiss P, Gretz N, Rehbein C, Keim V. The endothelin antagonist bosentan does not improve survival in severe experimental pancreatitis in rats. Int J Pancreatol 1999; 26: 147-154
13. Kogire M, Inoue K, Higashide SI, Takaori K, Echigo J, Gu YJ, Sumi S, Uchida K, Imamura M. Protective effects of endothelin-1 on acute pancreatitis in rats. Dig Dis Sci 1995; 40: 1207-1212
14. Yamaguchi H, Kimura T, Mimura K, Nawata H. Activation of proteases in cerulein-induced pancreatitis. Pancreas 1989; 4: 565-571
15. Kyogoku T, Manabe T, Tobe T. Role of ischemia in acute pancreatitis. Hemorrhagic shock converts edematous pancreatitis in rats. Dig Dis Sci 1992; 37: 1409-1417
16. Dlugosz JW, Wroblewski E, Poplawski C, Gabryelewicz A, Andrzejewska A. Does antecedent ethanol intake affect course of taurocholate pancreatitis in rats? Dig Dis Sci 1997; 42: 944-952
17. Andrzejewska A, Dlugosz JW, Jurkowska G. The effect of antecedent acute ethanol ingestion on the pancreas ultrastructure in taurocholate pancreatitis in rats. Exp Mol Path 1998; 65: 64-67
18. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of pancreatic secretagogue. Virchows Arch 1977; 373: 97-117
19. Takano S, Kimura T, Kawabuchi M, Yamaguchi H, Kinjo M, Nawata H. Ultrastructural study of the effects of stress on the pancreas in rats. Pancreas 1994; 9: 249-257
20. Watanabe O, Baccino FM, Steer ML, Meldolesi J. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: Early morphological changes during development of experimental pancreatitis. Am J Physiol 1984; 246(4 Pt 1): G457-467
21. Zhou ZG, Chen YD, Sun W, Chen Z. Pancreatic microcirculatory impairment in experimental acute pancreatitis in rats. World J Gastroenterol 2002; 8: 933-936
22. Klar E, Schratt W, Foitzik T, Buhr H, Herfarth C, Messmer K. Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbit pancreas. Dig Dis Sci 1994; 39: 2639-2644
23. Schmidt J, Ebeling D, Ryschich E, Werner J, Gebhard MM, Klar E. Pancreatic capillary blood flow in an improved model of necrotizing pancreatitis in the rat. J Surg Res 2002; 106: 335-341
24. Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ. Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. Ann Surg 1998; 228: 670-675
25. Klar E, Werner J. Neue pathophysiologische Kenntnisse der akuten Pankreatitis. Chirurg 2000; 71: 253-254
26. Cui P, Tani K, Kitamura H, Okumura Y, Yano M, Inui D, Tamaki T, Sone S, Kido H. A novel bioactive amino acid endothehn-1 is a potent chemotactic peptide for human neutrophils and monocytes. J Leukoc Biol 2001; 70: 306-312
27. A receptors and platelet-activating factor. Br J Pharmacol 1999; 127: 969-979
28. Brunelli A, Scutti G. An ultrastructural study to investigate the effect of allopurinol on cerulein-induced damage to pancreatic acinar cells in rat. Int J Pancreatol 1998; 23: 25-29
29. Grönroos JM, Aho HJ, Hietaranta AJ, Nevalainen TJ. Early acinar cell changes in caerulein-induced interstitial pancreatitis in the rat. Exp Path 1991; 41: 21-30
30. Amberg W, Hergenroder S, Hillen H, Jansen R, Kettschau G, Kling A, Klinge D, Raschack M, Riechers H, Unger L. Discovery and synthesis of (S)-3-[2-(3, 4-dimethoxyphenyl) etoxy]-2-(4,6-dimethylpyrimidin-2-yloxy)-3, 3-diphenylpropionic acid (LU 302872), a novel orally active mixed ET (A)/ET (B) receptor antagonist. J Med Chem 1999; 42: 3026-3032
31. Raschack M, Gock S, Unger L, Hahn A, Amberg W, Jansen R, Alken P, Weber A, Hergenroder S. LU 302872 and ist racemate (LU 224332) show balanced endothelin-A/B receptor affinity, high oral activity, and inhibit human prostate tissue contractions. J Cardiovasc Pharmacol 1998; 31(Suppl 1): S241-244
32. Knoll T, Oltersdorf J, Gottmann U, Schaub M, Michel MS, Kirchengast M, van der Woude FJ, Rohmeiss P, Braun C. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection. Transpl Int 2003; 16: 425-429
33. Wolf SC, Amend T, Risler T, Amann K, Brehm BR. Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy. Clin Sci 2002; 103 Suppl 48): 276S-279S